Combination PPARγand RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression

(2009) Joshua P Klopper et al.   Molecular Cancer

Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma

(2008) Agop Y. Bedikian et al.   CANCER INVESTIGATION

In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma

(2008) J. P. Klopper et al.   CLINICAL CANCER RESEARCH

Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?

(2008) Paul Lorigan et al.   EXPERIMENTAL DERMATOLOGY

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

(2008) Rebecca E. Schweppe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors

(2008) Daisuke Nonaka et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

(2008) Friederike Egberts et al.   ONKOLOGIE

A review of the S100 proteins in cancer

(2007) I. Salama et al.   EJSO